95 related articles for article (PubMed ID: 1532317)
1. Inhibition of neutral endopeptidase amplifies the effects of endogenous atrial natriuretic peptide on blood pressure and fluid partition.
Valentin JP; Qiu CB; Wiedemann E; Gardner D; Humphreys MH
Am J Hypertens; 1992 Feb; 5(2):88-91. PubMed ID: 1532317
[TBL] [Abstract][Full Text] [Related]
2. Modulation of ANP-dependent effects of endothelin by inhibitors of neutral endopeptidase and cGMP phosphodiesterase.
Valentin JP; Qiu C; Wiedemann E; Gardner DG; Humphreys MH
J Pharmacol Exp Ther; 1995 May; 273(2):744-52. PubMed ID: 7752077
[TBL] [Abstract][Full Text] [Related]
3. Modulation of endothelin effects on blood pressure and hematocrit by atrial natriuretic peptide.
Valentin JP; Gardner DG; Wiedemann E; Humphreys MH
Hypertension; 1991 Jun; 17(6 Pt 2):864-9. PubMed ID: 1828459
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive and renal activity of SQ 28,603, an inhibitor of neutral endopeptidase.
Seymour AA; Norman JA; Asaad MM; Fennell SA; Little DK; Kratunis VJ; Rogers WL
J Cardiovasc Pharmacol; 1991 Feb; 17(2):296-304. PubMed ID: 1709235
[TBL] [Abstract][Full Text] [Related]
5. Influence of dopamine receptor and adrenoceptor blockade on the hemoconcentrating and hypotensive actions of atrial natriuretic peptide.
Valentin JP; Ribstein J; Nafrialdi N; Mimran A
Can J Physiol Pharmacol; 1997 Sep; 75(9):1142-7. PubMed ID: 9365827
[TBL] [Abstract][Full Text] [Related]
6. Effects of the neutral endopeptidase inhibitor, SQ 28,603, on regional haemodynamic responses to atrial natriuretic peptide or proendothelin-1 [1-38] in conscious rats.
Gardiner SM; Kemp PA; Bennett T
Br J Pharmacol; 1992 May; 106(1):180-6. PubMed ID: 1387023
[TBL] [Abstract][Full Text] [Related]
7. Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11 and clearance receptors.
Seymour AA; Norman JA; Asaad MM; Fennell SA; Abboa-Offei B; Little DK; Kratunis VJ; Delaney NG; Hunt JT; Di Donato G
J Pharmacol Exp Ther; 1991 Mar; 256(3):1002-9. PubMed ID: 1826031
[TBL] [Abstract][Full Text] [Related]
8. Effects of neutral endopeptidase inhibition on the clearance of exogenously administered endothelin in Sprague-Dawley rats.
Asaad MM; Dorso CR; Moreland SM
J Cardiovasc Pharmacol; 1993 Apr; 21(4):633-6. PubMed ID: 7681910
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of SQ 28,603, an inhibitor of neutral endopeptidase, in conscious monkeys.
Seymour AA; Abboa-Offei B; Asaad MM; Rogers WL
Can J Physiol Pharmacol; 1991 Oct; 69(10):1609-17. PubMed ID: 1663819
[TBL] [Abstract][Full Text] [Related]
10. Heart failure augments the cardiovascular and renal effects of neutral endopeptidase inhibition in rats.
Trippodo NC; Gabel RA; Harvey CM; Asaad MM; Rogers WL
J Cardiovasc Pharmacol; 1991 Sep; 18(3):308-16. PubMed ID: 1720829
[TBL] [Abstract][Full Text] [Related]
11. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.
Kukkonen P; Vuolteenaho O; Ruskoaho H
Endocrinology; 1992 Feb; 130(2):755-65. PubMed ID: 1531129
[TBL] [Abstract][Full Text] [Related]
12. Blunted effect of ANP on hematocrit and plasma volume in streptozotocin-induced diabetes mellitus in rats.
Valentin JP; Sechi LA; Humphreys MH
Am J Physiol; 1994 Feb; 266(2 Pt 2):R584-91. PubMed ID: 8141419
[TBL] [Abstract][Full Text] [Related]
13. Neutral endopeptidase 24.11 inhibition reduces pulmonary vascular remodeling in rats exposed to chronic hypoxia.
Winter RJ; Zhao L; Krausz T; Hughes JM
Am Rev Respir Dis; 1991 Dec; 144(6):1342-6. PubMed ID: 1835825
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of brain natriuretic peptides by SQ 28,603, an inhibitor of neutral endopeptidase 3.4.24.11, in monkeys and rats.
Seymour AA; Asaad MM; Abboa-Offei BE; Rovnyak PL; Fennell S; Rogers WL
J Pharmacol Exp Ther; 1992 Jul; 262(1):60-70. PubMed ID: 1385630
[TBL] [Abstract][Full Text] [Related]
15. [Modulating effects of atrial natriuretic peptide on vascular permeability and blood pressure by inhibition of cyclic phosphodiesterase GMP in the rat].
Valentin JP; Humphreys MH
Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1219-22. PubMed ID: 1336359
[TBL] [Abstract][Full Text] [Related]
16. Endogenous angiotensin II but not atrial natriuretic peptide modulates the effect of nicardipine on extracellular fluid partition in the rat.
Valentin JP; Nafrialdi N; Ribstein J; Mimran A
J Hypertens; 1993 Sep; 11(9):961-7. PubMed ID: 8254178
[TBL] [Abstract][Full Text] [Related]
17. Effects of the ECE/NEP inhibitor CGS 34225 on the big ET-1-induced pressor response and plasma atrial natriuretic peptide concentration in conscious rats.
Trapani AJ; Beil ME; Bruseo CW; Fink CA; Hoyer D; Savage P; Jeng AY
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():102S-106S. PubMed ID: 12193065
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of kidney neutral endopeptidase (EC 3.4.24.11) and renal function in experimental cirrhosis.
Sansoè G; Aragno M; Mastrocola R; Cutrin JC; Silvano S; Mengozzi G; Smedile A; Rosina F; Danni O; Rizzetto M
Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1337-43. PubMed ID: 16449355
[TBL] [Abstract][Full Text] [Related]
19. Endogenous angiotensin II modulates the effect of atrial natriuretic peptide on extracellular fluid partition.
Valentin JP; Nafrialdi N; Ribstein J; Mimran A
Am J Physiol; 1993 Apr; 264(4 Pt 2):R676-80. PubMed ID: 8386485
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of neutral endopeptidase potentiates the effects of atrial natriuretic peptide on acute cyclosporin-induced nephrotoxicity.
Capasso G; Unwin R; Ciani F; Rizzo A; Russo F; Pica A; De Santo NG
Nephron; 2000 Nov; 86(3):298-305. PubMed ID: 11096287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
